The Malaysian healthcare industry has been robust in recent years. However, the CORONA VIRUS that grips all business sectors has also disrupt the healthcare industry. Immediate interventions need to be taken. Being the top player in ASEAN and a home to many multinationals and local pharma and medical device manufacturers, Malaysia surely has its own strategy to pivot during this trying time. Join us to understand opportunities available for UK exporters. This webinar brings together subject matter experts from the government and private sector to shed lights on:

• Impact of Covid-19 On Policy & Regulations
• Risk Management: A Perspective from a local industry that represent foreign pharmaceutical products & medical devices in the country
• Opportunities for UK Businesses
• What Should Companies do now to be ready for the future – post COVID-19.